发明名称 |
Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus |
摘要 |
This invention relates to methods for treating or preventing hepatitis C virus infections in mammals using Toll-Like Receptor (TLR)7 ligands and prodrugs thereof. More particularly, this invention relates to methods of orally administering a therapeutically effective amount of one or more prodrugs of TLR7 ligands for the treatment or prevention of hepatitis C viral infection. Oral administration of these TLR7 immunomodulating ligands and prodrugs thereof to a mammal provides therapeutically effective amounts and reduced undesirable side effects.
|
申请公布号 |
US8034802(B2) |
申请公布日期 |
2011.10.11 |
申请号 |
US20090493708 |
申请日期 |
2009.06.30 |
申请人 |
ANADYS PHARMACEUTICALS, INC. |
发明人 |
AVERETT DEVRON R. |
分类号 |
A01N43/00;A61K31/33;A61K31/4745;A61K31/513;A61K31/522;A61K31/7076;A61K31/708;A61P31/14 |
主分类号 |
A01N43/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|